VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CCEP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CCEPCoca-Cola Europacific Partners PLC
$101.06$44.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCCEPFinancials

Coca-Cola Europacific Partners PLC (CCEP) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has decelerated to 2.3% TTM, yet operating margin expanded to 13.6% in 2026Q2, reflecting stable gross margins of 35.3% and improved SG&A efficiency.

Income StatementBalance SheetCash FlowRatios

CCEP Income Statement

Annual statement

CCEP Income Statement

Coca-Cola Europacific Partners PLC (CCEP) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue42.23B20.9B20.44B18.3B17.32B13.76B10.61B12.02B11.52B11.06B9.13B7.02B6.22B5.96B6.11B6.39B5.05B15.11B15.66B14.36B15.01B15.79B13.39B13.76B16.09B17.65B15.7B14.32B11.44B10.25B6.36B
Revenue Growth %13.63%2.27%11.67%5.67%25.84%29.77%-11.74%4.33%4.12%21.12%30.13%12.89%4.26%-2.48%-4.33%26.61%-66.58%-3.56%9.09%-4.3%-4.99%17.91%-2.66%-14.5%-8.79%12.36%9.7%25.17%11.56%61.1%20.48%
Cost of Goods Sold27.24B13.46B13.15B11.57B11.08B8.66B6.81B7.42B7.06B6.77B5.58B4.45B3.99B3.88B3.92B4.05B3.18B9.31B9.89B8.89B9.08B9.44B7.95B8.07B9.93B10.95B9.67B8.96B6.2B5.59B3.43B
COGS % of Revenue-64.42%64.37%63.23%63.95%62.92%64.2%61.78%61.3%61.22%61.14%63.37%64.13%65.15%64.03%63.42%63.06%61.6%63.11%61.88%60.52%59.79%59.32%58.66%61.68%62.04%61.58%62.58%54.2%54.53%53.89%
Gross Profit15B7.44B7.28B6.73B6.24B5.1B3.8B4.59B4.46B4.29B3.55B2.57B2.23B2.08B2.2B2.34B1.86B5.8B5.78B5.47B5.92B6.35B5.45B5.69B6.17B6.7B6.03B5.36B5.24B4.66B2.93B
Gross Margin %35.51%35.58%35.63%36.77%36.05%37.08%35.8%38.22%38.7%38.78%38.86%36.63%35.87%34.85%35.97%36.58%36.94%38.4%36.89%38.12%39.48%40.21%40.68%41.34%38.32%37.96%38.42%37.42%45.8%45.47%46.11%
Gross Profit Growth %-2.1%8.23%7.78%22.34%34.4%-17.33%3.03%3.92%20.88%38.07%15.27%7.3%-5.51%-5.92%25.37%-67.86%0.4%5.56%-7.59%-6.72%16.53%-4.22%-7.76%-7.93%11.01%12.62%2.28%12.36%58.87%23.96%
Operating Expenses9.76B4.64B5.15B4.39B4.16B3.59B2.98B3.04B3.16B3.03B2.7B1.64B1.49B1.42B1.49B1.54B1.26B4.74B10.3B4.47B7.06B5.14B4.39B4.44B4.87B6.02B4.83B4.52B4.5B4.01B2.5B
OpEx % of Revenue-22.21%25.2%23.99%24%26.06%28.13%25.34%27.42%27.39%29.54%23.38%23.93%23.79%24.42%24.11%24.87%31.35%65.77%31.1%47.03%32.56%32.77%32.24%30.24%34.13%30.79%31.6%39.32%39.08%39.22%
Selling, General & Admin8.66B4.65B4.68B4.39B4.09B3.38B2.61B3.05B3.16B3.03B2.7B1.55B1.48B1.19B1.27B1.54B1.26B4.74B4.83B4.47B4.84B5.14B4.39B4.44B4.87B6.02B4.83B4.52B3.54B3.15B1.99B
SG&A % of Revenue-22.24%22.88%23.99%23.6%24.59%24.58%25.35%27.43%27.42%29.56%22.13%23.84%19.96%20.78%24.11%24.87%31.35%30.81%31.1%32.27%32.56%32.77%32.24%30.24%34.13%30.79%31.6%30.97%30.7%31.31%
Research & Development00000054M44M43M38M33M25M19M000000000000000000
R&D % of Revenue------0.51%0.37%0.37%0.34%0.36%0.36%0.31%------------------
Other Operating Expenses2M-5M475M-1M70M202M323M-45M-44M-41M-35M0002.27M00010.3B07.06B00000004.5B4.01B2.5B
Operating Income5.24B2.79B2.13B2.34B2.09B1.52B813M1.55B1.3B1.26B851M929.28M748M750.84M768.31M797.01M609.04M1.07B-4.52B1.01B-1.13B1.21B1.06B1.25B1.3B675.47M1.2B833.79M740.96M654.54M437.89M
Operating Margin %12.41%13.36%10.43%12.78%12.04%11.02%7.67%12.88%11.29%11.39%9.32%13.24%12.03%12.59%12.57%12.47%12.06%7.05%-28.89%7.02%-7.55%7.65%7.91%9.1%8.08%3.83%7.63%5.82%6.48%6.38%6.88%
Operating Income Growth %-31%-8.85%12.13%37.6%86.47%-47.48%19.08%3.17%48.06%-8.42%24.23%-0.38%-2.27%-3.6%30.86%-42.86%123.55%-548.79%189.01%-193.75%14.06%-15.4%-3.67%92.44%-43.66%43.79%12.53%13.2%49.48%19.97%
EBITDA6.53B3.43B2.77B3.12B2.86B2.24B1.42B2.15B1.79B1.72B1.2B1.2B957M970.86M1.02B1.04B807.54M1.79B-3.77B1.74B-365.96M2.09B1.85B2.12B2.3B2.2B2.54B2.17B1.7B1.51B941.67M
EBITDA Margin %15.46%16.41%13.53%17.05%16.5%16.26%13.38%17.87%15.54%15.52%13.13%17.14%15.39%16.28%16.7%16.34%16%11.87%-24.07%12.12%-2.44%13.23%13.79%15.43%14.26%12.45%16.18%15.18%14.83%14.77%14.8%
EBITDA Growth %14.66%24.05%-11.38%9.17%27.7%57.72%-33.94%20%4.25%43.2%-0.35%25.72%-1.43%-4.9%-2.28%29.37%-54.98%147.57%-316.69%575.47%-117.51%13.13%-13%-7.51%4.53%-13.59%16.94%28.15%11.98%60.84%21.1%
D&A (Non-Cash Add-back)1.29B637M633M781M772M722M606M600M490M457M348M273.9M209M220.02M252.56M247.67M198.5M727.97M754.26M731.82M766.78M881.46M787.84M871.05M995.85M1.52B1.34B1.34B954.98M860M503.78M
EBIT5.72B2.79B2.61B2.44B2.16B1.72B1.19B1.55B1.3B1.26B849M759M748M750.84M703.97M794.7M608.29M565.35M-4.54B1.01B-1.13B1.21B1.06B1.25B1.3B675.47M1.2B833.79M740.96M654.54M437.89M
Net Interest Income-419.22M-194.99M-187M-48M-114M-51.08M-126.54M-94.64M-96.06M-96.37M-124.38M-110M-89M-74.59M-71.08M-65.58M-47.37M-57.93M-421.67M000000000000
Interest Income111.32M98.93M55M114M17M44.83M37.62M48.3M48.55M46.26M32.68M103M84M000000000000000000
Interest Expense530.54M293.92M242M162M131M95.91M164.16M142.94M144.6M142.62M157.06M127M118M74.59M71.08M65.58M47.37M400.63M421.67M000000000000
Other Income/Expense-442M-224M-196M-136M-129M-134M-118M-94M-95M-101M-132M-115M-89M-78.94M-68.81M-67.9M-48.12M110.28M-432.44M-431.41M-472.04M-541.2M-455.89M-480.39M-628.01M-844.06M-844.34M-746.34M-596.86M-492.73M-282.02M
Pretax Income4.8B2.57B1.94B2.2B1.96B1.38B695M1.45B1.21B1.16B719M714.14M658M584.55M634.82M729.11M560.92M672.14M-4.96B576.82M-1.6B667M603.42M771.8M671.84M-168.59M354.56M87.45M144.1M161.82M155.87M
Pretax Margin %11.36%12.29%9.47%12.04%11.3%10.04%6.55%12.1%10.46%10.48%7.87%10.18%10.58%9.8%10.38%11.41%11.11%4.45%-31.65%4.02%-10.69%4.22%4.5%5.61%4.17%-0.96%2.26%0.61%1.26%1.58%2.45%
Income Tax1.2B590M492M534M436M394M197M364M296M471M170M145.27M174M100.21M121.35M151.22M91.73M161.93M-1.8B89.16M-738.75M233.03M163.76M235.03M201.08M-147.23M103.28M28.82M23.02M6.36M64.28M
Effective Tax Rate %24.92%22.97%25.41%24.24%22.28%28.51%28.35%25.03%24.56%40.64%23.64%20.34%26.44%17.14%19.12%20.74%16.35%24.09%36.33%15.46%46.03%34.94%27.14%30.45%29.93%87.33%29.13%32.95%15.98%3.93%41.24%
Net Income3.53B1.94B1.42B1.67B1.51B982M498M1.09B909M688M549M568.88M484M484.34M511.91M577.89M469.19M402.02M-3.16B487.65M-866.04M433.98M439.66M536.76M470.77M-360.78M251.28M58.63M121.08M155.45M91.6M
Net Margin %8.36%9.29%6.94%9.12%8.71%7.14%4.7%9.07%7.89%6.22%6.01%8.11%7.79%8.12%8.37%9.04%9.29%2.66%-20.15%3.4%-5.77%2.75%3.28%3.9%2.93%-2.04%1.6%0.41%1.06%1.52%1.44%
Net Income Growth %6.74%36.95%-15.04%10.68%53.56%97.19%-54.31%19.91%32.12%25.32%-3.49%17.54%-0.07%-5.38%-11.42%23.17%16.71%112.74%-747.26%156.31%-299.56%-1.29%-18.09%14.02%230.49%-243.58%328.56%-51.57%-22.11%69.72%43.22%
Net Income (Continuing)3.6B1.98B1.44B1.67B1.52B988M498M1.09B909M688M549M513M484M484.34M511.91M577.89M469.19M402.02M-3.16B487.65M-866.04M433.98M439.66M536.76M470.77M-21.35M251.28M58.63M121.08M155.45M91.6M
Discontinued Operations0000000000000000000000000000000
Minority Interest486.8M468M496M00177M0000000000016.05M15.8M000000000000
EPS (Diluted)7.914.093.083.643.292.151.092.321.921.321.502.421.921.771.701.771.380.82-6.511.00-1.820.910.931.161.03-0.840.580.130.300.390.24
EPS Growth %7.92%32.79%-15.38%10.64%53.02%97.25%-53.02%20.83%45.45%-12%-38.02%26.04%8.47%4.12%-3.95%28.26%68.29%112.6%-751%154.95%-300%-2.15%-19.83%12.62%222.62%-244.83%346.15%-56.67%-23.08%62.5%41.18%
EPS (Basic)-4.093.083.633.302.151.092.331.941.341.522.461.921.771.741.811.380.82-6.511.01-1.820.920.951.181.05-0.840.600.140.310.410.24
Diluted Shares Outstanding446M456M461M459M458M457M456M469M488M489M385M235M252M273M301M327M340M493M485M488M475M476M473M461M458M432M431.48M436M402.86M396M375M
Basic Shares Outstanding446M456M460.39M459M457M456M455M466M484M484M380M231M252M273M294M319M339M488M485M481M475M471M465M454M449M432M416.07M425M391.67M383M375M
Dividend Payout Ratio-45.85%64.17%50.39%50.6%64.97%77.51%52.66%56.44%71.08%37.16%40.78%38.22%31.93%27.62%21.63%6.41%25.52%-16.31%-14.79%12.75%10.95%15.18%-29.66%118.64%40.85%19.3%16.67%

Key Metrics

Growth RegimeDecelerating
ProfitabilityStable
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Revenue growth deceleration

Growth Deceleration Amid Integration

CCEP's revenue growth slowed to 4.4% in 2026Q2 from 39.9% in 2022Q2, reflecting a mature European base and the Amatil integration. According to the latest income statement, TTM growth is 2.3%, suggesting a transition to low-single-digit expansion.

The deceleration from double-digit growth in 2022 to mid-single digits in 2026 indicates that the post-acquisition boost has faded, and organic volume growth is likely modest. The 2026Q2 growth of 4.4% is an improvement over the 0.2% in 2025Q4, but this may be seasonal. Investors should monitor whether price/mix can sustain growth as volume remains challenged in developed markets.

Gross Margin Stability Under Pressure

Gross margin has remained remarkably stable around 35-36% over the past five years, with 2026Q2 at 35.3%. As reported in financial statements, this stability suggests effective pricing power despite input cost inflation, but it lags peers like KO and PEP.

The gross margin is structurally capped by the incidence pricing model with The Coca-Cola Company, which ties concentrate costs to retail prices. While CCEP has maintained margins through revenue growth management, the lack of expansion indicates limited pricing power beyond passing through costs. The 2023Q4 peak of 37.1% has not been revisited, suggesting potential pressure from packaging and commodity costs.

Operating Leverage Emerges in 2026

Operating margin expanded to 13.6% in 2026Q2, up from 9.3% in 2024Q4, as SG&A remained flat while revenue grew. Based on the income statement, this suggests improved overhead efficiency, but the 2025Q4 SG&A spike to $2.3B warrants scrutiny.

The operating margin recovery from 9.3% to 13.6% indicates that CCEP is leveraging its fixed cost base, particularly in distribution and administration. However, the SG&A line has been volatile, with 2025Q4 and 2024Q4 both at $2.3B, which may reflect one-time charges or investment. The 2026Q2 SG&A of $1.7B is notably lower, possibly due to timing, and investors should assess whether this is sustainable.

Earnings Volatility from Non-Operating Items

Net income swung from $621M in 2024Q4 to $1.0B in 2025Q4, with EPS growth of 69.4% in 2025Q4, despite flat revenue. As per the income statement, this suggests significant non-operating gains or tax benefits, warranting a closer look at earnings quality.

The 2024Q4 net margin of 5.9% was unusually low, likely due to impairment or restructuring charges, while 2025Q4's 9.7% margin appears more normalized. The EPS growth of 69.4% in 2025Q4 is not mirrored in revenue growth, indicating that bottom-line performance is influenced by items below the operating line. Stock-based compensation is minimal, but the tax rate and other income/expenses may be driving volatility.

COGS Dominates Cost Structure

COGS consistently represents about 64-65% of revenue, with 2026Q2 at $6.9B, reflecting the incidence pricing model. According to the income statement, this leaves limited room for margin expansion, as the largest cost is the concentrate from The Coca-Cola Company.

The cost structure is heavily weighted toward variable inputs, with COGS rising in tandem with revenue. SG&A has been relatively stable at around $2.2-2.3B in recent quarters, but the 2026Q2 drop to $1.7B is notable and may indicate cost discipline or timing. R&D is negligible, as expected for a bottler, so the focus is on managing COGS and SG&A efficiency.

2022 Acquisition Reshapes Scale

The 2022Q2 revenue surge of 39.9% marked the inflection point from the Coca-Cola Amatil acquisition, expanding CCEP's footprint into Asia-Pacific. As reported in financial statements, this transformed the company from a European player to a multi-continental bottler, but growth has since normalized.

The acquisition of Amatil in 2022 dramatically increased revenue and introduced emerging market exposure, particularly Indonesia. This inflection is evident in the revenue jump from $7.8B in 2021Q4 to $8.3B in 2022Q2, and the subsequent quarters show a new baseline. The lasting impact is a more diversified revenue stream, but also increased complexity and FX exposure, which may explain the recent growth deceleration.

Growth Slowdown Challenges Premium

Despite stable margins, CCEP's revenue growth has decelerated to 2.3% TTM, below peers like KDP and CELH. Short-sellers may argue that the company's mature European markets and limited innovation pipeline will cap growth, making its valuation premium unjustified.

The deceleration in revenue growth, particularly the -1.77% YoY reported in recent context, suggests that CCEP may be losing share or facing volume declines in core markets. The reliance on The Coca-Cola Company for product innovation is a risk, as the brand owner's pipeline may not deliver growth in non-soda categories. Additionally, the high leverage (D/E of 1.29) could constrain investment in growth initiatives, and regulatory costs from packaging and sugar taxes may pressure margins further.

CCEP — Frequently Asked Questions

Quick answers to the most common questions about buying CCEP stock.

What was Coca-Cola Europacific Partners PLC's (CCEP) revenue in 2025?

For fiscal year 2025, Coca-Cola Europacific Partners PLC (CCEP) reported total revenue of $20.90B. This represents a 228.4% increase compared to $6.36B in 1996.

Is Coca-Cola Europacific Partners PLC (CCEP) profitable?

Coca-Cola Europacific Partners PLC (CCEP) is profitable, generating $1.94B in net income for the fiscal year ending 2025 with a net profit margin of 9.3%.

What is Coca-Cola Europacific Partners PLC's operating profit margin?

Coca-Cola Europacific Partners PLC (CCEP) reported an operating income of $2.79B, resulting in an operating profit margin of 13.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Coca-Cola Europacific Partners PLC's gross profit and gross margin?

Coca-Cola Europacific Partners PLC (CCEP) generated $7.44B in gross profit for the year, representing a gross profit margin of 35.6%. This demonstrates the company's core pricing power and production efficiency.